Long-term Benefits of Continuous Positive Pressure Therapy or Mandibular Advancement Devise on the Sleep of Patients With Obstructive Sleep Apnea

Status: Recruiting
Location: See all (9) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY

The REMAP study aims to follow a cohort of 400 patients in around ten sleep centers in France and to collect clinical routine data. The objectives of this study are to investigate the effects of one-year management of OSA by CPAP or MAD on sleep architecture defined by objective macro and micro sleep architecture parameters using a sleep test device. sleep connected at home, to assess the quality of sleep and the quality of life reported by patients. The study will also allow us to define predictive factors for improving sleep quality during OSA treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Patient already included in the SunSAS study (No. ID/RCB: 2021-A01827-34) or Patient who has undergone polygraphy or polysomnography eligible for treatment with CPAP or MAD in the context of OSA.

• Patient with a sleep test performed with the Sunrise device

• Men or Women from 18 to 80 years old

• Patient with OSAS eligible for CPAP or MAD therapy

• Affiliated patient or beneficiary of a social security scheme

• Signed informed consent

Locations
Other Locations
France
CHU Angers
RECRUITING
Angers
Centre Hospitalier Universitaire Grenoble Alpes
RECRUITING
Grenoble
CHU Lyon - Hôpital de la Croix-Rousse
RECRUITING
Lyon
Hopital Europeen Marseille
RECRUITING
Marseille
AP-HP Bichat
NOT_YET_RECRUITING
Paris
APHP - Pitié-Salpêtrière University Hospital
RECRUITING
Paris
CHU Reims
RECRUITING
Reims
Polyclinique St Laurent
RECRUITING
Rennes
Centre du Sommeil
RECRUITING
Saint-martin-d'hères
Contact Information
Primary
Elodie Aversenq
elodie.aversenq@resmed.fr
+33426100200
Backup
Florent Lavergne
florent.lavergne@resmed.fr
+33426100200
Time Frame
Start Date: 2022-07-15
Estimated Completion Date: 2026-10-15
Participants
Target number of participants: 400
Treatments
Patient treated with CPAP
Patient treated with MAD
Related Therapeutic Areas
Sponsors
Leads: ResMed

This content was sourced from clinicaltrials.gov